On the heels of joining the Digital Therapeutics Alliance, we wrote a white paper about some of the key factors that led to our current mental health crisis, and the promise of DTx to help address this crisis. We are committed to a crucial and long-overdue paradigm shift: establishing evidentiary standards, clearance processes, and reimbursement frameworks for DTx. But we don’t stop there. Gaming is at the heart of our vision. Luckily, this means more science, not less… Read our full piece below:
Arcade Therapeutics
心理健康保健
New York，NY 1,362 位关注者
We make therapeutic games for mental well-being, supported by rigorous evidence.
关于我们
Arcade Therapeutics is a science-first game studio dedicated to treating mental illness by combining the most cutting edge cognitive neuroscience with engaging games. Our NYC-based team includes leaders in clinical research, consumer products, game development, and healthcare strategy. Arcade was named a 2024 Digital Health NY 100 Company, and was named to the Global HealthTech 250 by Galen Growth. Arcade’s non-prescription anxiety game, StarStarter, is available to manage symptoms of anxiety for ages 13+. The company is also pursuing FDA submissions for its pipeline of therapeutic games targeting indications including social anxiety disorder, generalized anxiety disorder, major depressive disorder, alcohol use disorder as well as mental health conditions related to pregnancy and multiple sclerosis. With Arcade Connect, we deliver these treatments integrated into healthcare workflows, allowing for seamless distribution from provider to patient, reporting and support for reimbursement. Please connect with us to learn more and become a partner as we work together to change the game in mental health.
- 网站
-
https://www.arcadetherapeutics.com
Arcade Therapeutics的外部链接
- 所属行业
- 心理健康保健
- 规模
- 2-10 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
获取路线
US，NY，New York，10018
Arcade Therapeutics员工
-
Anish Shindore
I am not a scientist nor a doctor, I am a human concerned for OUR health, contributing via digital/ tech solutions
-
Benjamin Baker
Operations & Strategy | Digital Health and Behavioral Health Innovation
-
Anika Mahajan
Student @ Rutgers Honors College/ Rutgers Business School 2027
动态
-
Come see our CEO Raj Amin at this new event showcasing thought leaders in DTx across pharma, DTx makers, and payers on the front lines in Boston Feb 11-12. Early registration expires next week Nov 22nd!
The golden age of DTx is here! In the past 12 months alone, the digital therapeutics (DTx) field has experienced explosive growth, with over 50 new solutions entering clinical trials and regulatory pipelines. We've seen ground-breaking advancements in treating chronic diseases, mental health conditions, and neurological disorders, with several DTx platforms now achieving FDA approvals and demonstrating real-world impact. ??But What’s Next for Digital Therapeutics? When Will the Next Wave of DTx Approvals Reach Patients? Are you a leader in the digital therapeutics space, eager to drive your work forward and collaborate with over key innovators shaping the future of digital healthcare? Don’t miss out on your opportunity to join Otsuka Pharmaceutical Companies (U.S.), Dario, Sanofi, AppliedVR, Arcade Therapeutics, and many more at the Boston Advancing Digital Therapeutics Summit (11th February- 12th February). This summit will bring together the most expert leaders within the DTx space, with an extensive Agenda, exciting workshops and excellent networking opportunities. Our early-registration deadline will be expiring next Friday (22nd November), saving you and your team up to $600 off passes. Interested? To find out more on this years meeting and how to secure your discounted pass, please either drop me a message on LinkedIn or send an email to [email protected] #DTx #DigitalTherapeutics #DigitalHealthcare #CMS #CMSpaymentcodes #AdvancingDigitalTherapeutics #Boston
-
Sending a huge congrats to our colleagues at Big Health for paving the way forward with a first FDA clearance for their digital treatment for Generalized Anxiety Disorder. Having an ecosystem of digital mental health treatments available to treat patients with varying preferences and levels of severity will be crucial to stemming our mental health crisis.
We’re excited to share more big news.. DaylightRx has received FDA clearance! ?? The US Food and Drug Administration has granted clearance for DaylightRx, our digital treatment for generalized anxiety disorder. This milestone comes just weeks after the FDA granted clearance for SleepioRx, our digital treatment for insomnia. There have been limited options for patients seeking non-drug treatments for anxiety for far too long, so we’re thrilled to be able to offer an FDA-cleared digital treatment that is safe and effective with a remission rate of over 70%. Full press release: https://lnkd.in/gPRjmfye Read more about the impact of this latest clearance: https://lnkd.in/gj-em9gf #anxiety #digitaltherapeutics #digitaltreatments
-
-
We are incredibly excited to partner with Omni to impact the lives of children and families in need. Let’s keep changing the game in mental health!
Omni is proud to partner with Arcade Therapeutics to begin offering StarStarter, an innovative therapeutic mobile game for managing anxiety symptoms, to those we serve, ages 13 and up.?Based on decades of neuroscience research, StarStarter retrains the brain’s subconscious patterns of attention while playing a simple and fun game, right on your phone. For more information on Arcade, reach out to Arcade Therapeutics, and for more information on bringing Omni behavioral health services to your community along with innovative treatments like this, reach out to?Gwen Koenig, [email protected].
-
-
Co-founder and CSO at Arcade Therapeutics & Author of Future Tense: Why Anxiety is Good for You (Even Though it Feels Bad)
Those of us in health tech are in a period of introspection because the world at large is coming to grips with the costs and benefits of digital technology. We work as researchers, entrepreneurs, care providers, knowledge disseminators - we know health tech's potential but we also know how it's gone wrong. So, here's our job - figure out how to take the best that digital tech has to offer and build THAT. To do this well, we need a north star, a moral compass to keep us focused on promoting human flourishing and not risk sabotaging it. A north star I believe in the most: health technology should have the potential to be an ?? on-ramp to human connection.?? What do I mean? I mean health tech should have these characteristics: ? It does its job and then it gets us back to IRL; ?It promotes human connection, it doesn’t disrupt it;? ?It strengthens and deepens existing care relationships, it doesn't replace them; ?It relieves human caregiving burden, stress, and overwhelm - whether in medical settings, educational, parenting, or beyond; ?It must meet people where they are, rejecting the ‘if we build it they will come’ approach; ?It solves a problem better than a human-centered solution would. Remember if it ain’t broke, that's not where we should start fixing; These are our practices and aspirations at Arcade Therapeutics and I know a lot of other companies out there are doing the same. Weigh in on these ideas, add additional principles, and give a shout out to your own company or one you respect! Doing this work is hard. We have to stick together.
-
“Products need to have a high degree of clinical data to support their claims, so it won’t help typical ‘wellness’ products, but is great for those with solid clinical research supporting their medical claims,” says #HealthTransformer Raj Amin of StartUp Health company Arcade Therapeutics on new proposal for three new codes that would reimburse doctors for the usage of FDA-approved digital tools in mental health treatment. Read more in Fast Company ?? https://ow.ly/3K4I50SCMw3
Medicare could soon start covering digital mental health therapies
fastcompany.com
-
Great to see real world data like this shared about how digital therapeutics are impacting outcomes and the cost of care, in this case saving almost $5K per patient annually. Medication alone won’t solve the problem, but a combination of digital, human, and pharma offerings could.
Refreshing to hear a pharma company acknowledge that drugs only impact a very small part (10-15%) of health outcomes (in lifestyle related conditions) , and that the most important driver of outcomes is behavior - confirming the enormous potential of digital therapeutics as essential - fully integrated - part of a holistic treatment approach (and how this proves to save $5K per patient per year...) Erez Raphael Hakim Yadi Ph.D. OBE David Benshoof Klein Felix Lee
A partnership between pharma and digital therapeutics
mobihealthnews.com
-
?DID YOU KNOW? The proposed 2025 Physician Fee Schedule includes significant advancements for digital therapeutics! CMS has proposed new payments and coding for "digital mental health treatment (DMHT) devices”? as a physician service.? ??This is the first time CMS has provided Medicare reimbursable codes for digital therapeutic products. See what DTA Chief Operating Officer Jessica Hauflaire and DTA member Raj Amin have to say about the new codes in Healthcare Brew. Read "What CMS' proposed reimbursement codes could mean for the digital therapeutics industry" here: https://lnkd.in/eTR682e2 #DTA #DTx #digitaltherapeutics #digitalhealth #mentalhealth #CMS #Medicare
What CMS’s proposed reimbursement codes could mean for the digital therapeutics industry
healthcare-brew.com
-
BIG NEWS! In a watershed moment for digital therapeutics, Medicare has proposed 2025 reimbursement for Digital Mental Health Treatments (DHMTs). More below, including nice mention of Arcade with our CEO quoted. A rising tide of digital interventions in healthcare is here! https://lnkd.in/e3Hf7PEX
Medicare could soon start covering digital mental health therapies
fastcompany.com